Literature DB >> 7764659

Enhanced production of human monoclonal antibodies by the use of fructose in serum-free hybridoma culture media.

K Mochizuki1, S Sato, M Kato, S Hashizume.   

Abstract

It was found that the production of human monoclonal antibodies (MoAbs) by human-human hybridomas can be significantly enhanced by replacing glucose with fructose in the dish culture medium. Optimization of initial concentrations of fructose and glutamine, another influencing factor for MoAb production, enabled an enhanced production of human MoAb 2.1 times higher than that obtained using the conventional culture media employing glucose. It was shown by kinetic analysis that enhanced MoAb production at the optimum fructose concentration can be attributed to the retention of high specific antibody production rates and diminished time lag during the course of culture. These dish culture results with fructose-containing medium were successfully applied to the continuous perfusion culture with a slight modification, where 2.9- and 1.9-fold enhancements in specific antibody production rate and MoAb concentration, respectively, were attained as compared with the conventional glucose-containing medium. An inverse relationship was observed between the secreted concentrations of lactic acid and MoAb when the hybridoma was cultured in the media containing varying concentrations of fructose, i.e., the lower the lactic acid concentration, the higher the MoAb production and vice versa, suggesting that fructose at appropriate concentrations in the medium can serve as an alternative sugar for the efficient production of human MoAbs, with reduced pH shifts, for the serum-free culture of human-human hybridomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764659     DOI: 10.1007/BF00749812

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Maximisation of perfusion systems and process comparison with batch-type cultures. Maximisation of perfusion cultures.

Authors:  J B Griffiths; D Looby; A J Racher
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Batch production and growth kinetics of hybridomas.

Authors:  O W Merten
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

3.  Monoclonal antibody production in semi-continuous serum- and protein-free culture. Effect of glutamine concentration and culture conditions on cell growth and antibody secretion.

Authors:  Y J Schneider; A Lavoix
Journal:  J Immunol Methods       Date:  1990-05-25       Impact factor: 2.303

4.  Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.

Authors:  M B Khazaeli; M N Saleh; R H Wheeler; W J Huster; H Holden; R Carrano; A F LoBuglio
Journal:  J Natl Cancer Inst       Date:  1988-08-17       Impact factor: 13.506

Review 5.  Process development for hybridoma cells.

Authors:  C Harbour; J P Barford; K S Low
Journal:  Adv Biochem Eng Biotechnol       Date:  1988       Impact factor: 2.635

6.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

7.  Stimulation of monoclonal antibody production by human-human hybridoma cells with an elevated concentration of potassium or sodium phosphate in serum-free medium.

Authors:  S Sato; H Murakami; T Sugahara; T Ikegami; K Yamada; H Omura; S Hashizume
Journal:  Cytotechnology       Date:  1989-02       Impact factor: 2.058

8.  Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations.

Authors:  K Low; C Harbour
Journal:  Dev Biol Stand       Date:  1985

9.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

10.  Characterization of a lung cancer-associated human monoclonal antibody HB4C5.

Authors:  K Mochizuki; M Kato; S Sato; S Hashizume; H Murakami; K Nomoto
Journal:  Hum Antibodies Hybridomas       Date:  1991-07
View more
  4 in total

1.  Effect of culture temperature on a recombinant CHO cell line producing a C-terminal α-amidating enzyme.

Authors:  K Furukawa; K Ohsuye
Journal:  Cytotechnology       Date:  1998-03       Impact factor: 2.058

2.  Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.

Authors:  M Yamaguchi; Y Shirai; Y Inouye; M Shoji; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

3.  Efficient production of recombinant IgG by metabolic control and co-expression with GLUT5 in a fructose-based medium.

Authors:  Yuichi Inoue; Yuriko Tsukamoto; Makoto Yamanaka; Shigeki Nakamura; Aiko Inoue; Norikazu Nishino; Hiroharu Kawahara
Journal:  Cytotechnology       Date:  2010-08-10       Impact factor: 2.058

4.  Enhanced CEA production associated with aspirin in a culture of CW-2 cells on some polymeric films.

Authors:  A Higuchi; S Uchiyama; M Demura; T Asakura; C S Cho; T Akaike; H Takarada; M Hara
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.